The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Slides:

Advertisements

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results M. Ferreira, L. Lanziotti, M. Monteiro, G.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Revised duplex criteria and outcomes for renal stents and stent grafts following endovascular repair of juxtarenal and thoracoabdominal aneurysms Walid.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Freedom from secondary interventions to treat stenotic disease after percutaneous transluminal angioplasty of infrarenal aorta: long-term results J.P.P.M.

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions Tomoharu Dohi,

Stenting of femoropopliteal lesions using interwoven nitinol stents

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions Takao Ohki, MD, PhD, Kimihiko.

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal.

Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Duplex ultrasound criteria for femorofemoral bypass revision

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

One-year pivotal trial outcomes of the Nellix system for endovascular aneurysm sealing Jeffrey P. Carpenter, MD, Robert Cuff, MD, Clifford Buckley, MD,

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Durability of open popliteal artery aneurysm repair

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Open versus endovascular treatment of subclavian artery atherosclerotic disease George C. Galyfos, MD, PhD, Ioannis Kakisis, MD, PhD, Chrisostomos Maltezos,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,

In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia Todd R. Vogel, MD, MPH, Viktor.

Abd Moain Abu Dabrh, MBBCh, MS, Mark W

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Thomas A. Simone, MD, Benjamin S. Brooke, MD, PhD, Philip P

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative Jeffrey J. Siracuse, MD, Matthew.

Critical analysis of results after chimney endovascular aortic aneurysm repair raises cause for concern Salvatore T. Scali, MD, Robert J. Feezor, MD,

Atherosclerotic renovascular disease among hypertensive adults

Jon S. Matsumura, MD, Germano Melissano, MD, Richard P

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Balloon angioplasty for revision of failing lower extremity bypass grafts Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Evaluation of the Endurant stent graft under instructions for use vs off-label conditions for endovascular aortic aneurysm repair Giovanni Torsello,

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Philip P. Goodney, MD, MS, Adam W. Beck, MD, Jan Nagle, MS, RPh, H

Rabih A. Chaer, MD, Joel E. Barbato, MD, Stephanie C

Effect of chronic oral anticoagulation with warfarin on the durability and outcomes of endovascular aortic aneurysm repair Marques S. Johnson, MD, Jasmine.

Reconstructive surgery for complex aortoiliac occlusive disease in young adults Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca.

Revised duplex criteria and outcomes for renal stents and stent grafts following endovascular repair of juxtarenal and thoracoabdominal aneurysms Walid.

A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease Tiziano Tallarita, MD, Gustavo S. Oderich, MD,

Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia Catherine K. Chang, MD, Salvatore.

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Endovascular interventions for TASC II D femoropopliteal lesions

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II) Jon S. Matsumura, MD, Dai Yamanouchi, MD, PhD, Jeffrey A. Goldstein, MD, Christopher W. Pollock, MD, Marc Bosiers, MD, Greg A. Schultz, MD, Dierk Scheinert, MD, Krishna J. Rocha-Singh, MD Journal of Vascular Surgery Volume 58, Issue 1, Pages 73-83.e1 (July 2013) DOI: 10.1016/j.jvs.2012.12.066 Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 1 A, Protégé EverFlex Self-Expanding Peripheral Stent cut in an open lattice design showing spiral cell connectors, three-wave peaks, peak-to-peak connection nodes, and tantalum markers at the proximal and distal ends of the stent; available in stent lengths of 20, 30, 40, 60, 80, 100, 120, 150, and 200 mm. B, A 200-mm stent is depicted. Journal of Vascular Surgery 2013 58, 73-83.e1DOI: (10.1016/j.jvs.2012.12.066) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 2 Kaplan-Meier estimate of freedom from loss of primary patency defined as peak systolic velocity (PSV) ratio <2.0 and no clinically driven reintervention within the stented segment. # At Risk gives the number of patients at risk of an event at the start of the interval, whereas # Censored and # Events are the incremental counts of patients censored or with events during the interval. CI, Confidence interval. Journal of Vascular Surgery 2013 58, 73-83.e1DOI: (10.1016/j.jvs.2012.12.066) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier estimate of freedom from loss of assisted primary patency defined as peak systolic velocity (PSV) ratio <2.0 maintained by repeated percutaneous intervention completed before complete vessel occlusion. # At Risk gives the number of patients at risk of an event at the start of the interval, whereas # Censored and # Events are the incremental counts of patients censored or with events during the interval. CI, Confidence interval. Journal of Vascular Surgery 2013 58, 73-83.e1DOI: (10.1016/j.jvs.2012.12.066) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 4 Kaplan-Meier estimates of freedom from loss of secondary patency. Secondary patency was defined as peak systolic velocity (PSV) ratio <2.0 maintained by repeat percutaneous intervention after occlusion of the target lesion. # At Risk gives the number of patients at risk of an event at the start of the interval, whereas # Censored and # Events are the incremental counts of patients censored or with events during the interval. CI, Confidence interval. Journal of Vascular Surgery 2013 58, 73-83.e1DOI: (10.1016/j.jvs.2012.12.066) Copyright © 2013 Society for Vascular Surgery Terms and Conditions